Merskey H, Bogduk N, eds. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Task force on Taxonomy of the International Association for the Study of Pain. Seattle, WA: IASP Press; 1994:39-43.
Harden RN, Bruehl SP, Stanton-Hicks M, et al. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8:326-331.
Cossins L, Okell RW, Cameron H, et al. Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012. Eur J Pain. 2013;17:158-173.
O'Connell NE, Wand BM, McAuley J, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev. 2013;(4):CD009416.
Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Ann Vasc Surg. 2008;22:297-306.
1. Merskey H, Bogduk N, eds. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Task force on Taxonomy of the International Association for the Study of Pain. Seattle, WA: IASP Press; 1994:39-43.
2. Jensen TS, Baron R, Haanpää M, et al. A new definition of neuropathic pain. Pain. 2011;152:2204-2205.
3. van der Laan L, ter Laak HJ, Gabreels-Festen A, et al. Complex regional pain syndrome type I (RSD): pathology of skeletal muscle and peripheral nerve. Neurology. 1998;51:20-25.
4. Albrecht PJ, Hines S, Eisenberg E, et al. Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain. 2006;120:244-266.
5. Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small fiber neuropathy? Ann Neurol. 2009;65:629-638.
6. Del Piñal F. Editorial: I have a dream ... reflex sympathetic dystrophy (RSD or Complex Regional Pain Syndrome - CRPS I) does not exist. J Hand Surg Eur Vol. 2013;38:595-597.
7. Borchers AT, Gershwin ME. Complex regional pain syndrome: a comprehensive and critical review. Autoimmun Rev. 2014;13:242-265.
8. Campero M, Bostock H, Baumann TK, et al. A search for activation of C nociceptors by sympathetic fibers in complex regional pain syndrome. Clin Neurophysiol. 2010;121:1072-1079.
10. Sandroni P, Benrud-Larson LM, McClelland RL, et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain. 2003;103:199-207.
11. de Mos M, de Bruijn AG, Huygen FJ, et al. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129:12-20.
12. Bickerstaff DR, Kanis JA. Algodystrophy: an under-recognized complication of minor trauma. Br J Rheumatol. 1994;33:240-248.
13. Atkins RM, Duckworth T, Kanis JA. Features of algodystrophy after Colles fracture. J Bone Joint Surg Br. 1990;72-B:105-110.
14. Atkins RM. Complex regional pain syndrome. J Bone Joint Surg Br. 2003;85-B:1100-1106.
15. Veldman PH, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012-1016.
16. Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010;113:713-725.
17. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895-926.
18. Birklein F, Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett. 2008;437:199-202.
19. Benarroch EE. Central neuron-glia interactions and neuropathic pain. Neurology. 2010;75:273-278.
20. Saab CY, Hains BC. Remote neuroimmune signaling: a long-range mechanism of nociceptive network plasticity. Trends Neurosci. 2009;32:110-117.
21. Smith HS, Albrecht PJ, Rice FL. Complex regional pain syndrome: pathophysiology. In: Smith HS (ed). Current therapy in pain. Philadelphia, PA: Saunders Elsevier; 2009:295-309.
22. Parkitny L, McAuley JH, Di Pietro F, et al. Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology. 2013;80:106-117.
23. Birklein F, Drummond P, Li W, et al. Activation of cutaneous immune responses in complex regional pain syndrome. J Pain. 2014;15:485-495.
24. Goebel A, Blaes F. Complex regional pain syndrome, prototype of a novel kind of autoimmune disease. Autoimmun Rev. 2013;12:682-686.
25. Tékus V, Hajna Z, Borbély É, et al. A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome. Pain. 2014;155:299-308.
26. Li WW, Guo TZ, Shi X, et al. Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain. 2014;155:2377-2389.
27. Kohr D, Singh P, Tschernatsch M, et al. Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain. 2011;152:2690-2700.
28. Maihöfner C, Baron R, DeCol R, et al. The motor system shows adaptive changes in complex regional pain syndrome. Brain. 2007;130:2671-2687.
29. Oaklander AL, Birklein F. Factor I: sensory changes - pathophysiology and measurement. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:59-79.
30. Wasner G, Baron R. Factor II: vasomotor changes - pathophysiology and measurement. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:81-106.
31. Lima MC, Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008;70:2329-2337.
32. Andre-Obadia N, Mertens P, Gueguen A, et al. Pain relief by rTMS: differential effect of current flow but no specific action on pain subtypes. Neurology. 2008;71:833-840.
33. Butler SH. Disuse and CRPS. In: Harden RN, Baron R, Janig W, eds. Complex regional pain syndrome. Seattle, WA: IASP Press; 2001:141-150.
34. Harden RN, Bruehl SP, Stanton-Hicks M, et al. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8:326-331.
35. van Velzen GA, Perez RS, van Gestel MA, et al. Health-related quality of life in 975 patients with complex regional pain syndrome. Pain. 2014;155:629-634.
36. Wuppenhorst N, Maier C, Frettlöh J, et al. Sensitivity and specificity of 3-phase bone scintigraphy in the diagnosis of complex regional pain syndrome of the upper extremity. Clin J Pain. 2010;26:182-189.
37. Oaklander AL, Rissmiller JG, Gelman LB, et al. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy). Pain. 2006;120:235-243.
38. Ringer R, Wertli M, Bachmann LM, et al. Concordance of qualitative bone scintigraphy results with presence of clinical complex regional pain syndrome 1: meta-analysis of test accuracy studies. Eur J Pain. 2012;16:1347-1356.
39. Schott GD. Interrupting the sympathetic outflow in causalgia and reflex sympathetic dystrophy: a futile procedure for many patients. BMJ. 1998;316:792-793.
40. Burton AW, Lubenow TR, Raj PP. Traditional interventional therapies. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:217-233.
41. Schott GD. Complex? Regional? Pain? Syndrome? Pract Neurol. 2007;7:145-157.
42. Freeman R, Chase KP, Risk MR. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology. 2003;60:465-470.
43. Wasner G, Schattschneider J, Heckmann K, et al. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain. 2001;124:587-599.
44. Sandroni P, Wilson PR. Factor III: sudomotor changes and edema - pathophysiology and measurement. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:107-118.
45. Daly AE, Bialocerkowski AE. Does evidence support physiotherapy management of adult Complex Regional Pain Syndrome Type One? A systematic review. Eur J Pain. 2009;13:339-353.
46. Viezi IE, Chelimsky TC, Janata JW. Chronic regional pain syndrome: what specialized rehabilitation services do patients require? Curr Pain Headache Rep. 2012;16:139-146.
47. Cossins L, Okell RW, Cameron H, et al. Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012. Eur J Pain. 2013;17:158-173.
48. Harden RN, Oaklander AL, Burton AW, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Medicine. 2013;14:180-229.
49. O'Connell NE, Wand BM, McAuley J, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev. 2013;(4):CD009416.
50. Schilder JC, Sigtermans MJ, Schouten AC, et al. Pain relief is associated with improvement in motor function in complex regional pain syndrome type 1: secondary analysis of a placebo-controlled study on the effects of ketamine. J Pain. 2013;14:1514-1521.
51. Geertzen JHB, Harden RN. Physical and occupational therapies. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:173-179.
52. Harden RN, Swan M, King A, et al. Treatment of complex regional pain syndrome: functional restoration. Clin J Pain. 2006;22:420-424.
53. Moseley GL. Graded motor imagery for pathologic pain: a randomized controlled trial. Neurology. 2006;67:2129-2134.
54. Cacchio A, De Blasis E, De Blasis V, et al. Mirror therapy in complex regional pain syndrome type 1 of the upper limb in stroke patients. Neurorehabil Neural Repair. 2009;23:792-799.
55. Rothgangel AS, Braun SM, Beurskens AJ, et al. The clinical aspects of mirror therapy in rehabilitation: a systematic review of the literature. Int J Rehabil Res. 2011;34:1-13.
56. Al Sayegh S, Filén T, Johansson M, et al. Mirror therapy for Complex Regional Pain Syndrome (CRPS) - a literature review and an illustrative case report. Scand J Pain. 2013;4:200-207.
57. Zyluk A, Puchalski P. Treatment of early complex regional pain syndrome type 1 by a combination of mannitol and dexamethasone. J Hand Surg Eur Vol. 2008;33:130-136.
58. Oaklander AL. Evidence-based pharmacotherapy for CRPS and related conditions. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:181-200.
59. Sharma A, Williams K, Raja SN. Advances in treatment of complex regional pain syndrome: recent insights on a perplexing disease. Cur Opin Anaesthesiol. 2006;19:566-572.
60. Yanow J, Pappagallo M, Pillai L. Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. ScientificWorldJournal. 2008;8:229-236.
61. Brunner F, Schmid A, Kissling R, et al. Biphosphonates for the therapy of complex regional pain syndrome I - systematic review. Eur J Pain. 2009;13:17-21.
62. Sellmeyer DE. Atypical fractures as a potential complication of long-term bisphosphonate therapy. JAMA. 2010;304:1480-1484.
63. Baqain ZH, Sawair FA, Tamimi Z, et al. Osteonecrosis of jaws related to intravenous bisphosphonates: the experience of a Jordanian teaching hospital. Ann R Coll Surg Engl. 2010;92:489-494.
64. Varenna M, Adami S, Rossini M, et al. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology (Oxford). 2013;52:534-542.
65. Agarwal S, Polydefkis M, Block B, et al. Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states. Pain Med. 2007;8:554-562.
66. European Medicines Agency. European Medicines Agency recommends limiting long-term use of calcitonin medicines. July 2012. http://www.ema.europa.eu/ (last accessed 9 January 2017).
67. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
68. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003;4:109-121.
69. Barlos P, Lundeberg T. Transcutaneous electrical nerve stimulation and acupuncture. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack's textbook of pain. 5th ed. Philadelphia, PA: Elsevier/Churchill Livingstone; 2006:583-590.
70. Verdugo RJ, Ochoa JL. 'Sympathetically maintained pain.' I. Phentolamine block questions the concept. Neurology. 1994;44:1003-1010.
71. Verdugo RJ, Campero M, Ochoa JL. Phentolamine sympathetic block in painful polyneuropathies. II. Further questioning the concept of 'sympathetically maintained pain'. Neurology. 1994;44:1010-1014.
72. Schott GD. An unsympathetic view of pain. Lancet. 1995;345:634-636.
74. Cepeda MS, Lau J, Carr DB. Defining the therapeutic role of local anesthetic sympathetic blockade in complex regional pain syndrome: a narrative and systematic review. Clin J Pain. 2002;18:216-233.
75. Cepeda MS, Carr DB, Lau J. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev. 2005;(4):CD004598.
76. Straube S, Derry S, Moore RA, et al. Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome. Cochrane Database Syst Rev. 2013;(9):CD002918.
77. de Oliveira Rocha R, Teixeira MJ, Yeng LT, et al. Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: a double-blind randomized controlled study. Pain. 2014;155:2274-2281.
78. Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Ann Vasc Surg. 2008;22:297-306.
79. Stanton-Hicks M, Rauck RL, Hendrickson M, et al. Miscellaneous and experimental therapies. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:255-274.
80. Lubenow TR, Buvanendran A, Stanton-Hicks M. Implanted therapies. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: current diagnosis and therapy. Seattle, WA: IASP Press; 2005:235-253.
81. Grabow TS, Tella PK, Raja SN. Spinal cord stimulation for complex regional pain syndrome: an evidence-based medicine review of the literature. Clin J Pain. 2003;19:371-383.
82. Forouzanfar T, Kemler MA, Weber WE, et al. Spinal cord stimulation in complex regional pain syndrome: cervical and lumbar devices are comparably effective. Br J Anaesth. 2004;92:348-353.
83. Turner JA, Loeser JD, Deyo RA, et al. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications. Pain. 2004;108:137-147.
84. Taylor RS, Van Buyten JP, Buchser E. Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors. Eur J Pain. 2006;10:91-101.
85. National Institute for Health and Care Excellence. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. October 2008. http://www.nice.org.uk/TA159 (last accessed 9 January 2017).
86. Cruccu G, Aziz TZ, Garcia-Larrea L, et al. European Federation of Neurological Societies (EFNS) guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14:952-970.
87. Simpson EL, Duenas A, Holmes MW, et al. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess. 2009;13:iii;ix-x;1-154.
88. Stanton-Hicks M. Complex regional pain syndrome: manifestations and the role of neurostimulation in its management. J Pain Symptom Manage. 2006;31(4 suppl):S20-S24.
89. Ranoux D, Attal N, Morain F, et al. Botulinum type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol. 2008;64:274-283.
90. Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol. 2009;65:348-351.
91. Kiefer RT, Rohr R, Ploppa A, et al. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients. Pain Med. 2008;9:44-54.
92. Correll GE, Maleki J, Gracely EJ, et al. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 2004;5:263-275.
93. Kiefer RT, Rohr R, Ploppa A, et al. Complete recovery from intractable complex regional pain syndrome, CRPS-type 1, following anesthetic ketamine and midazolam. Pain Pract. 2007;7:147-150.
94. Schwartzman RJ, Alexander GM, Grothusen JR, et al. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009;147:107-115.
95. Azari P, Lindsay DR, Briones D, et al. Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review. CNS Drugs. 2012;26:215-228.
96. Collins S, Sigtermans MJ, Dahan A, et al. NMDA receptor antagonists for the treatment of neuropathic pain. Pain Med. 2010;11:1726-1742.
97. Gustin SM, Schwarz A, Birbaumer N, et al. NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain. 2010;151:69-76.
98. Perez RS, Zuurmond WW, Bezemer PD, et al. The treatment of complex regional pan syndrome type I with free radical scavengers: a randomized controlled study. Pain. 2003;102:297-307.
99. Dirckx M, Stronks DL, Groeneweg G, et al. Effect of immunomodulating medications in complex regional pain syndrome: a systematic review. Clin J Pain. 2012;28:355-363.
100. de Mos M, Huygen FJ, van der Hoeven-Borgman M, et al. Outcome of the complex regional pain syndrome. Clin J Pain. 2009;25:590-597.
101. Schwartzman RJ, Erwin KL, Alexander GM. The natural history of complex regional pain syndrome. Clin J Pain. 2009;25:273-280.
102. Wertli M, Bachmann LM, Weiner SS, et al. Prognostic factors in complex regional pain syndrome 1: a systematic review. J Rehabil Med. 2013;45:225-231.
103. Gierthmühlen J, Binder A, Baron R. Mechanism-based treatment in complex regional pain syndromes. Nat Rev Neurol. 2014;10:518-528.
104. Birklein F, O’Neill D, Schlereth T. Complex regional pain syndrome: an optimistic perspective. Neurology. 2015;84:89-96.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台